LNSR Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

20.30M

+21.33%

-0.070

-95.65%

19.00M

+34.19%

-0.090

-96.12%

20.30M

+45.68%

0.010

-106.67%

Estimates Revision

The market is revising No Change the revenue expectations for LENSAR, Inc. (LNSR) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -2.67%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-2.67%

In Past 3 Month

Valuation Metrics

The current forward P/E ratio for LENSAR Inc (LNSR.O) is -89.31, compared to its 5-year average forward P/E of -13.22. For a more detailed relative valuation and DCF analysis to assess LENSAR Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-13.22

Current PE

-89.31

Overvalued PE

8.96

Undervalued PE

-35.40

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

4.14

Current EV/EBITDA

48.59

Overvalued EV/EBITDA

79.21

Undervalued EV/EBITDA

-70.93

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.52

Current PS

1.76

Overvalued PS

2.18

Undervalued PS

0.86

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds areSelling! The selling amount has increased 303.64% over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

LNSR News & Events

Events Timeline

No data

News

5.0

2025-08-19Newsfilter

Elizabeth O'Farrell Joins the Board of Directors at SpyGlass Pharma

5.0

2025-08-19Globenewswire

Elizabeth O’Farrell Joins the Board of Directors at SpyGlass Pharma

7.0

2025-06-15Globenewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ATAI, ICAD on Behalf of Shareholders

People Also Watch

Frequently Asked Questions

What is LENSAR Inc (LNSR) stock price today?

The current price of LNSR is 11.67 USD — it has increased 1.21 % in the last trading day.

What is LENSAR Inc (LNSR)'s business?

LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The Company has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.

What is the price predicton of LNSR Stock?

Wall Street analysts forecast LNSR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LNSR is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is LENSAR Inc (LNSR)'s revenue for the last quarter?

LENSAR Inc revenue for the last quarter amounts to 14.32M USD, increased 5.74 % YoY.

What is LENSAR Inc (LNSR)'s earnings per share (EPS) for the last quarter?

LENSAR Inc. EPS for the last quarter amounts to -0.31 USD, increased 138.46 % YoY.

What changes have occurred in the market's expectations for LENSAR Inc (LNSR)'s fundamentals?

How many employees does LENSAR Inc (LNSR). have?

LENSAR Inc (LNSR) has 140 emplpoyees as of January 09 2026.

What is LENSAR Inc (LNSR) market cap?

Today LNSR has the market capitalization of 139.39M USD.